Whitehawk Therapeutics Inc
(WHWK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,176 | -8,493 | -10,397 | -1,878 | -13,416 |
| Depreciation Amortization | 34 | 13 | 47 | 35 | 24 |
| Accounts payable and accrued liabilities | -2,046 | -1,714 | 1,865 | 53 | N/A |
| Other Working Capital | -1,308 | -1,220 | 1,110 | -544 | 18,033 |
| Other Operating Activity | 3,272 | 2,335 | 1,567 | 2,711 | 1,957 |
| Operating Cash Flow | $-14,224 | $-9,078 | $-5,808 | $377 | $6,599 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -233 | -113 | -38 | -29 | -9 |
| Investing Cash Flow | $-233 | $-113 | $-38 | $-29 | $-9 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 44,999 |
| Common Stock Issued | N/A | N/A | 51,698 | 51,698 | 24 |
| Other Financing Activity | 0 | 0 | -3,503 | -3,503 | -3,094 |
| Financing Cash Flow | $N/A | $N/A | $48,196 | $48,196 | $41,929 |
| Beginning Cash Position | 62,614 | 62,614 | 20,264 | 20,264 | 20,264 |
| End Cash Position | 48,157 | 53,423 | 62,614 | 68,807 | 68,783 |
| Net Cash Flow | $-14,457 | $-9,192 | $42,350 | $48,543 | $48,519 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,224 | -9,078 | -5,808 | 377 | 6,599 |
| Capital Expenditure | -233 | -113 | -38 | -29 | -9 |
| Free Cash Flow | -14,457 | -9,192 | -5,846 | 347 | 6,590 |